Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Review Article

SRP. 2020; 11(4): 223-228


Immunohistochemistry Study Urothelial Carcinoma using Tumor Markers (EGFR, EMA and CD117)

Ebtihal Chiad Abass, Alaa Salah Jumaah, Kaswer Musa Jaafar Altoriah, Hawraa Sahib Al-Haddad, Aseel Al-Quzweni, Hussein Raof Alghaszali, Najah R. Hadi.

Abstract
The aim of the present is to determine the immunohistochemical expression of EGFR, EMA and CD117 in case of urinary bladder transitional cell carcinoma and their relation with staging of tumor and its impact on further prognosis. EGFR immunohistochemical study showing (61.5 %) positive in case of urinary bladder carcinoma with significant difference between staging of tumor (p value 0.019) with signification expression between low grade and high grade tumor with P value 0.002 (6.2%) positivity in high grade versus (15.4 %) positivity in low grade). EMA showing strong positivity in urothelial carcinoma 96.2% without significant difference between staging and grading of tumor with p valve of (0.57) and (0.227) respectively CD117 immunohistochemical study showing total positive cases of urinary bladder carcinoma of 69.2% with significant difference in comparison with staging and grading of tumor with (P-value=0.00) for each respectively. Our result demonstrate that EGFR and CD 117 immunohistochemical staining showing strong positivity in majority of urothelial carcinoma cases with significant relation to both pathological grading and staging of tumor. Application of both markers may play a role to give idea about behavior of tumor and possibility of further recurrence with and even direct therapy application EMA showing strong positive expression which give idea about tumor origin from epithelial lining. It had no benefit in assessment of tumor grading and staging

Key words: urothelial carcinoma, EGFR. EMA, CD117



Similar Articles

Redundant roles of EGFR ligands in the ERK activation waves during collective cell migration.
Lin S, Hirayama D, Maryu G, Matsuda K, Hino N, Deguchi E, Aoki K, Iwamoto R, Terai K, Matsuda M
Life science alliance. 2022; 5(1):

Magnetic Resonance Imaging of Perineural Spread of Head and Neck Cancer.
Abdelaziz TT, Abdel Razek AAK
Magnetic resonance imaging clinics of North America. 2022; 30(1): 95-108

Synchronous early-stage breast cancer and axillary follicular lymphoma diagnosed by core needle biopsy: A case report.
Eto R, Nakamura R, Yamamoto N, Miyaki T, Hayama S, Sonoda I, Itami M, Tsujimura H, Hashimoto H, Otsuka M
Molecular and clinical oncology. 2022; 16(1): 3

IRF2-induced Claudin-7 suppresses cell proliferation, invasion and migration of oral squamous cell carcinoma.
Li X, Yang W
Experimental and therapeutic medicine. 2022; 23(1): 7

MR Imaging of Nasopharyngeal Carcinoma.
King AD
Magnetic resonance imaging clinics of North America. 2022; 30(1): 19-33


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites